Literature DB >> 2242506

Actigraphy: a means of assessing circadian patterns in human activity.

A C Brown1, M H Smolensky, G E D'Alonzo, D P Redman.   

Abstract

Twenty-three diurnally active (0705-2333), healthy persons between 22 and 54 years of age and without history of sleep abnormality were monitored continuously for 120 consecutive hr (five days) by wrist actigraphy. Circadian rhythms of high amplitude were detected by cosinor analysis for each participant and for the groups of 10 males and 13 females with the average span of heightened activity timed between approximately 1330 and 1605. The circadian peak-trough difference in wrist movement was marked, equalling approximately 75% of the 24-hr mean level. In 19 of 23 participants, the 24-hr mean of wrist activity varied between 140-180 movements/min, with four persons exhibiting lesser means of 110-140 movements/min. With respect to the daytime span of activity, the mean wrist movement of individual participants ranged from 155-265 movements/min, with the majority (20/23) varying between 185-245 movements/min. During nocturnal sleep the mean wrist activity level was quite low, varying between individuals from 5 to 25 movements/min for 21 of 23 persons. Wrist actigraphy proved to be well-accepted and was a most reliable means of monitoring aspects of body movement during activity and sleep in ambulatory persons adhering to usual life habits and pursuits.

Entities:  

Mesh:

Year:  1990        PMID: 2242506     DOI: 10.3109/07420529009056964

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  25 in total

1.  Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women.

Authors:  Gregory J Tranah; Terri Blackwell; Katie L Stone; Sonia Ancoli-Israel; Misti L Paudel; Kristine E Ensrud; Jane A Cauley; Susan Redline; Teresa A Hillier; Steven R Cummings; Kristine Yaffe
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

2.  Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy.

Authors:  Andrea Barsevick; Susan L Beck; William N Dudley; Bob Wong; Ann M Berger; Kyra Whitmer; Tracey Newhall; Susan Brown; Katie Stewart
Journal:  J Pain Symptom Manage       Date:  2010-06-18       Impact factor: 3.612

3.  Actigraphy: analyzing patient movement.

Authors:  Mary Jo Grap; Virginia A Hamilton; Ann McNallen; Jessica M Ketchum; Al M Best; Nyimas Y Isti Arief; Paul A Wetzel
Journal:  Heart Lung       Date:  2010-08-17       Impact factor: 2.210

4.  Actimetry in sleep medicine.

Authors:  O Kellner; H Bastuji; P Adeleine
Journal:  Sleep Breath       Date:  1997-03       Impact factor: 2.816

Review 5.  The relationship between fatigue and sleep in cancer patients: a review.

Authors:  S Ancoli-Israel; P J Moore; V Jones
Journal:  Eur J Cancer Care (Engl)       Date:  2001-12       Impact factor: 2.520

6.  Marker rhythms for chronotherapy of cancer.

Authors:  M Smolensky; L T Campos
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Cognition in older women: the importance of daytime movement.

Authors:  Deborah E Barnes; Terri Blackwell; Katie L Stone; Suzanne E Goldman; Teresa Hillier; Kristine Yaffe
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

8.  Circadian research in mothers and infants: how many days of actigraphy data are needed to fit cosinor parameters?

Authors:  Karen A Thomas; Robert L Burr
Journal:  J Nurs Meas       Date:  2008

9.  Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy.

Authors:  Ann M Berger; Kimberly Wielgus; Melody Hertzog; Patricia Fischer; Lynne Farr
Journal:  Support Care Cancer       Date:  2009-04-19       Impact factor: 3.603

10.  Diurnal effects of motor activity and fatigue in Parkinson's disease.

Authors:  J J van Hilten; G Hoogland; E A van der Velde; H A Middelkoop; G A Kerkhof; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.